Page last updated: 2024-10-27

flecainide and Pulmonary Stenoses

flecainide has been researched along with Pulmonary Stenoses in 1 studies

Flecainide: A potent anti-arrhythmia agent, effective in a wide range of ventricular and atrial ARRHYTHMIAS and TACHYCARDIAS.
flecainide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 2,5-bis(2,2,2-trifluoroethoxy)benzoic acid with the primary amino group of piperidin-2-ylmethylamine. An antiarrhythmic agent used (in the form of its acetate salt) to prevent and treat tachyarrhythmia (abnormal fast rhythm of the heart).

Research Excerpts

ExcerptRelevanceReference
"We discovered supraventricular tachycardia with advanced hydrops in the setting of normal cardiac anatomy at 26 weeks of gestation which resolved successfully following administration of digoxin and flecainide to the mother."3.70Fetal hydrops due to a tachyarrhythmia progressing to organic pulmonary stenosis. ( Fesslova, V; Nicolini, U; Villa, L, 2000)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fesslova, V1
Villa, L1
Nicolini, U1

Other Studies

1 other study available for flecainide and Pulmonary Stenoses

ArticleYear
Fetal hydrops due to a tachyarrhythmia progressing to organic pulmonary stenosis.
    Cardiology in the young, 2000, Volume: 10, Issue:2

    Topics: Adult; Anti-Arrhythmia Agents; Digoxin; Echocardiography, Doppler; Female; Flecainide; Humans; Hydro

2000